Keywords: novartis, neoral, performs, well, study, swiss, drug

Novartis' Neoral performs well in study

Article | 31 July 2006

Print This

Swiss drug major Novartis says that the results of a large head-to-head study has shown that Neoral (cyclosporine), an immunosuppressant, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in